rs765596650
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000545.8(HNF1A):c.1502-14T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000122 in 1,613,626 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000545.8 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HNF1A | NM_000545.8 | c.1502-14T>C | intron_variant | Intron 7 of 9 | ENST00000257555.11 | NP_000536.6 | ||
HNF1A | NM_001306179.2 | c.1502-14T>C | intron_variant | Intron 7 of 9 | NP_001293108.2 | |||
HNF1A | NM_001406915.1 | c.1310-14T>C | intron_variant | Intron 6 of 8 | NP_001393844.1 | |||
HNF1A | XM_024449168.2 | c.1502-14T>C | intron_variant | Intron 7 of 8 | XP_024304936.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HNF1A | ENST00000257555.11 | c.1502-14T>C | intron_variant | Intron 7 of 9 | 1 | NM_000545.8 | ENSP00000257555.5 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 151958Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000878 AC: 22AN: 250530Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 135674
GnomAD4 exome AF: 0.000127 AC: 186AN: 1461550Hom.: 0 Cov.: 32 AF XY: 0.000149 AC XY: 108AN XY: 727084
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152076Hom.: 0 Cov.: 33 AF XY: 0.0000941 AC XY: 7AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
- -
- -
Maturity onset diabetes mellitus in young Benign:1
Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. However, more evidence is required to confer the association of this particular variant rs765596650 with MODY3. -
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at